Prostate News Archive
09-Sep-2009
For Men, a Saving Surgery: Twenty-Five Years Ago, Patrick C. Walsh Devised a Prostate-Cancer Operation That Allowed ... (RedNova)
By Marie McCullough, The Philadelphia Inquirer Apr. 30--In 1982, the surgical cure for prostate cancer was considered worse than the disease. Removing the prostate meant life-threatening bleeding, guaranteed impotence, and a 1 in 4 chance of incontinence. Women 'more distressed by prostate cancer' (Perth Now)
WOMEN are more distressed by prostate cancer than their male partners who are diagnosed with the disease, a study has found. The Risk Of Renal Impairment In Hormone-Refractory Prostate Cancer Patients With Bone Metastases Treated With ... (Medical News Today)
UroToday.com- Nearly one-quarter of prostate cancer (CaP) patients treated with zoledronic acid (ZA) suffer renal impairment according to a report by Dr. Oh and colleagues in the online version of Cancer.ZA is an intravenous bisphosphonate given to decrease skeletal related events in CaP patients with bone metastases. [click link for full article] Cesium-131 From IsoRay Medical (TM), Inc. Established as a Front Line Treatment for Early Stage Prostate Cancer ... (Business Wire via Yahoo! Finance)
CHICAGO----Investigators of a recent multi-institutional trial, led by principal investigator Bradley Prestidge, conclude that Cesium-131, a medical isotope used in low dose brachytherapy treatment for prostate cancer, "... has come into widespread use; and the clinical results of this trial are mature enough to be of immediate, important, practical use to practitioners." EPCA-2 testing more accurate way to identify cancer in the prostate (News-Medical-Net)
New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2 (EPCA-2), may change the way men are screened for prostate cancer - a disease that kills tens of thousands of men every year.
Back to Prostate News Archive
